摘要
目的:观察丹红注射液治疗肝硬化的临床疗效。方法:选择肝功能异常以及血清肝纤维化指标异常的肝硬化患者82例,随机分为治疗组(42例)和对照组(40例)。治疗组在常规护肝治疗基础上,静脉点滴丹红注射液(丹参、红花),对照组给予常规的护肝治疗,疗程均为30天。观察治疗后2组肝功能及肝纤维化指标(HA、LN、IV-C、PC-III)变化。结果:肝功能(TBil、ALT等)2组疗效无显著性差异,但血清肝纤维化指标2组有显著性差异(P<0.05或P<0.01)。结论:丹红注射液能有效地改善肝病患者微循环,降低肝脏纤维化,对肝硬化的治疗具有良好的前景。
Objective：To investigate effects of Danhong Injection on liver cirrhosis.Methods：Eighty-two patients with liver cirrhosis were randomized to two groups,i.e. control group （n=42） and treatment group （n=40）. Danhong Injection was given to treatment group,as an add-on treatment to routine treatment,over a period of 30 days. At end of the treatment period,liver function and cirrhosis parameters（HA、LN、IV-C、PC-III） were observed. Results：Significant differences were measured between two group with plasma cirrhosis parameters （P0.05 or P0.01）,but not with liver function parameters （TBil,ALT etc.）. Conclusion：Danhong Injection can improve microcirculation of the patients with liver illness,decrease liver cirrhosis,thus present promising prospects.
出处
《世界中医药》
CAS
2011年第1期26-27,共2页
World Chinese Medicine
关键词
肝硬化/中医药疗法
丹红注射液
Liver cirrhosis /Chinese Medical therapy
Danhong Injection
